Clinical evaluation of Siddha drug Gowri Chinthamani Chendhooram in the management of Vatha Moothira Kirichuram with special reference to Benign Prostatic Hyperplasia

Ramalingam Shanmugam

doi:10.5455/jrtm.2019/64123

J. res. tradit. med. 2019; 5(3-4): 34-39

doi: 10.5455/jrtm.2019/64123

Clinical evaluation of Siddha drug Gowri Chinthamani Chendhooram in the management of Vatha Moothira Kirichuram with special reference to Benign Prostatic Hyperplasia

Ramalingam Shanmugam.

Abstract
Background: Benign Prostatic Hyperplasia (BPH) is a non-carcinogenic (benign) growth of the cells within the prostate gland which is the most common condition affecting men older than 40 years of age. The reason behind this phenomenon is still unsolved, but moreover, this happens due to the tumour growth factor of the prostate gland. BPH symptoms can be related to the condition of a decreased amount of urine (Neerinai Arugal Noi). In Siddha classification, the symptoms of BPH are almost correlated with the symptoms of Vatha Moothira Kirichuram, a type of Moothira Kirichuram with the clinical feature of less amount of urine with increased frequency of voiding. Siddhar Agathiyar mentioned the Siddha drug, Gowri Chinthamani Chendhooram (GCC), a mineralo-mettalic preparation for Moothira Kirichuram in his text named, Agathiyar Vaithiya Kaviyam 1500. Based on these evidences open clinical trial was done and the reports are discussed here.

Aim: To evaluate the clinical efficacy of GCC, Siddha drug in the management of Vatha Moothira Kirichuram (BPH).

Materials and Methods: Open clinical study with 20 patients fulfilling the inclusion criteria were selected from OPD, administered with a dose of 100mg GCC, twice a day after food for 48 days with Avarai-ver Kuzhi Thylam as an adjuvant.

Observations and results: GCC showed statistically significant relief in the subjective and objective parameters considered for BPH.

Conclusion: Overall effect of Siddha drug GCC suggests that the drug was safe and effective in improving the outcome of the disease condition, IPSS index and the USG findings.

Key words: BPH, Gowri Chinthamani Chendhooram, IPSS, Moothira Kirichuram

	ARTICLE TOOLS
	Abstract
	PDF Fulltext
	ePub Reader
	How to cite this article
	Citation Tools
	Related Records
	Articles by Ramalingam Shanmugam
	on Google
	on Google Scholar

How to Cite this Article

Pubmed Style

Ramalingam Shanmugam. Clinical evaluation of Siddha drug Gowri Chinthamani Chendhooram in the management of Vatha Moothira Kirichuram with special reference to Benign Prostatic Hyperplasia. J. res. tradit. med. 2019; 5(3-4): 34-39. doi:10.5455/jrtm.2019/64123

Web Style

Ramalingam Shanmugam. Clinical evaluation of Siddha drug Gowri Chinthamani Chendhooram in the management of Vatha Moothira Kirichuram with special reference to Benign Prostatic Hyperplasia. https://www.tmjournal.org/?mno=64123 [Access: December 05, 2023]. doi:10.5455/jrtm.2019/64123

AMA (American Medical Association) Style

Ramalingam Shanmugam. Clinical evaluation of Siddha drug Gowri Chinthamani Chendhooram in the management of Vatha Moothira Kirichuram with special reference to Benign Prostatic Hyperplasia. J. res. tradit. med. 2019; 5(3-4): 34-39. doi:10.5455/jrtm.2019/64123

Vancouver/ICMJE Style

Ramalingam Shanmugam. Clinical evaluation of Siddha drug Gowri Chinthamani Chendhooram in the management of Vatha Moothira Kirichuram with special reference to Benign Prostatic Hyperplasia. J. res. tradit. med. (2019), [cited December 05, 2023]; 5(3-4): 34-39. doi:10.5455/jrtm.2019/64123

Harvard Style

Ramalingam Shanmugam (2019) Clinical evaluation of Siddha drug Gowri Chinthamani Chendhooram in the management of Vatha Moothira Kirichuram with special reference to Benign Prostatic Hyperplasia. J. res. tradit. med, 5 (3-4), 34-39. doi:10.5455/jrtm.2019/64123

Turabian Style

Ramalingam Shanmugam. 2019. Clinical evaluation of Siddha drug Gowri Chinthamani Chendhooram in the management of Vatha Moothira Kirichuram with special reference to Benign Prostatic Hyperplasia. JOURNAL OF RESEARCH IN TRADITIONAL MEDICINE, 5 (3-4), 34-39. doi:10.5455/jrtm.2019/64123

Chicago Style

Ramalingam Shanmugam. "Clinical evaluation of Siddha drug Gowri Chinthamani Chendhooram in the management of Vatha Moothira Kirichuram with special reference to Benign Prostatic Hyperplasia." JOURNAL OF RESEARCH IN TRADITIONAL MEDICINE 5 (2019), 34-39. doi:10.5455/jrtm.2019/64123

MLA (The Modern Language Association) Style

Ramalingam Shanmugam. "Clinical evaluation of Siddha drug Gowri Chinthamani Chendhooram in the management of Vatha Moothira Kirichuram with special reference to Benign Prostatic Hyperplasia." JOURNAL OF RESEARCH IN TRADITIONAL MEDICINE 5.3-4 (2019), 34-39. Print. doi:10.5455/jrtm.2019/64123

APA (American Psychological Association) Style

Ramalingam Shanmugam (2019) Clinical evaluation of Siddha drug Gowri Chinthamani Chendhooram in the management of Vatha Moothira Kirichuram with special reference to Benign Prostatic Hyperplasia. JOURNAL OF RESEARCH IN TRADITIONAL MEDICINE, 5 (3-4), 34-39. doi:10.5455/jrtm.2019/64123